Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.

Bettini S, Bordigato E, Milan G, Dal Pra' C, Favaretto F, Belligoli A, Sanna M, Serra R, Foletto M, Prevedello L, Busetto L, Fassina G, Vettor R, Fabris R.

Obes Facts. 2019;12(3):291-306. doi: 10.1159/000499717. Epub 2019 May 17.

2.

The contribution of legal medicine in clinical risk management.

Bolcato M, Fassina G, Rodriguez D, Russo M, Aprile A.

BMC Health Serv Res. 2019 Feb 1;19(1):85. doi: 10.1186/s12913-018-3846-7.

3.

Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients.

Gallotta A, Paneghetti L, Mrázová V, Bednárová A, Kružlicová D, Frecer V, Miertus S, Biasiolo A, Martini A, Pontisso P, Fassina G.

Int J Biol Markers. 2018 May;33(2):231-236. doi: 10.1177/1724600817753577. Epub 2018 May 1.

PMID:
29712495
4.

Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.

Bui Huu H, Ha Thuc N, Thi Le HP, Thi Thanh TD, Luong Bac A, Tiribelli C, Pontisso P, Gallotta A, Paneghetti L, Fassina G.

Scand J Clin Lab Invest. 2018 May;78(3):204-210. doi: 10.1080/00365513.2018.1432072. Epub 2018 Jan 30.

PMID:
29381084
5.

Clinical evaluation of the iXip index to reduce prostate re-biopsies.

Galosi AB, Dell'Atti L, Bertaccini A, Gion M, Francavilla S, Ferretti S, Maestroni U, Gallotta A, Parrozzani C, Paneghetti L, Fassina G.

Cancer Treat Res Commun. 2018;16:59-63. doi: 10.1016/j.ctarc.2018.07.001. Epub 2018 Jul 19.

PMID:
31299004
6.

Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.

Guarino M, Di Costanzo GG, Gallotta A, Tortora R, Paneghetti L, Auriemma F, Tuccillo C, Fassina G, Caporaso N, Morisco F.

Scand J Clin Lab Invest. 2017 Oct;77(6):448-453. doi: 10.1080/00365513.2017.1336569. Epub 2017 Jun 13.

PMID:
28609160
7.

Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C.

Martini A, Gallotta A, Pontisso P, Fassina G.

World J Hepatol. 2015 Dec 18;7(29):2913-9. doi: 10.4254/wjh.v7.i29.2913. Review.

8.

Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.

Biasiolo A, Trotta E, Fasolato S, Ruvoletto M, Martini A, Gallotta A, Fassina G, Angeli P, Gatta A, Pontisso P.

Dig Liver Dis. 2016 Feb;48(2):197-202. doi: 10.1016/j.dld.2015.10.022. Epub 2015 Oct 31.

PMID:
26614642
9.

HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.

Martini A, Fattovich G, Guido M, Bugianesi E, Biasiolo A, Ieluzzi D, Gallotta A, Fassina G, Merkel C, Gatta A, Negro F, Pontisso P.

J Viral Hepat. 2015 Oct;22(10):800-8. doi: 10.1111/jvh.12394. Epub 2015 Jan 22.

10.

A novel algorithm for the prediction of prostate cancer in clinically suspected patients.

Gallotta A, Ziglioli F, Ferretti S, Maestroni U, Moretti M, Aloe R, Gnocchi C, Di Palo M, Fassina G.

Cancer Biomark. 2013;13(4):227-34. doi: 10.3233/CBM-130357.

PMID:
24240583
11.

Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.

Biasiolo A, Tono N, Zaninotto M, Merkel C, Fassina G, Plebani M, Gatta A, Pontisso P.

J Med Virol. 2013 Jun;85(6):1005-8. doi: 10.1002/jmv.23493.

PMID:
23588726
12.

IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.

Biasiolo A, Tono N, Ruvoletto M, Quarta S, Turato C, Villano G, Beneduce L, Fassina G, Merkel C, Gatta A, Pontisso P.

PLoS One. 2012;7(7):e40658. doi: 10.1371/journal.pone.0040658. Epub 2012 Jul 13.

13.

Dental identification by comparison of antemortem and postmortem dental radiographs: influence of operator qualifications and cognitive bias.

Pinchi V, Norelli GA, Caputi F, Fassina G, Pradella F, Vincenti C.

Forensic Sci Int. 2012 Oct 10;222(1-3):252-5. doi: 10.1016/j.forsciint.2012.06.015. Epub 2012 Jul 5.

PMID:
22770720
14.

Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.

Kongkamnerd J, Cappelletti L, Prandi A, Seneci P, Rungrotmongkol T, Jongaroonngamsang N, Rojsitthisak P, Frecer V, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.

Bioorg Med Chem. 2012 Mar 15;20(6):2152-7. doi: 10.1016/j.bmc.2012.01.026. Epub 2012 Jan 26.

PMID:
22342267
15.

Biomarkers quantification with antibody arrays in cancer early detection.

Gallotta A, Orzes E, Fassina G.

Clin Lab Med. 2012 Mar;32(1):33-45. doi: 10.1016/j.cll.2011.11.001. Epub 2011 Dec 15. Review. No abstract available.

PMID:
22340842
16.

Structural refinement of protein A mimetic peptide.

Dinon F, Salvalaglio M, Gallotta A, Beneduce L, Pengo P, Cavallotti C, Fassina G.

J Mol Recognit. 2011 Nov-Dec;24(6):1087-94. doi: 10.1002/jmr.1157.

PMID:
22038815
17.

A screening assay for neuraminidase inhibitors using neuraminidases N1 and N3 from a baculovirus expression system.

Kongkamnerd J, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.

J Enzyme Inhib Med Chem. 2012 Feb;27(1):5-11. doi: 10.3109/14756366.2011.568415. Epub 2011 Jul 8.

PMID:
21740106
18.

The quenching effect of flavonoids on 4-methylumbelliferone, a potential pitfall in fluorimetric neuraminidase inhibition assays.

Kongkamnerd J, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Monthakantirat O, Umehara K, De-Eknamkul W, Miertus S.

J Biomol Screen. 2011 Aug;16(7):755-64. doi: 10.1177/1087057111409221. Epub 2011 Jun 2.

PMID:
21636741
19.

Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD.

Turato C, Biasiolo A, Pengo P, Frecer V, Quarta S, Fasolato S, Ruvoletto M, Beneduce L, Zuin J, Fassina G, Gatta A, Pontisso P.

Exp Biol Med (Maywood). 2011 Mar;236(3):281-90. doi: 10.1258/ebm.2011.010229. Epub 2011 Mar 7.

PMID:
21383048
20.

Solid-phase preparation of protein complexes.

Pengo P, Veggiani G, Rattanamanee K, Gallotta A, Beneduce L, Fassina G.

J Mol Recognit. 2010 Nov-Dec;23(6):551-8. doi: 10.1002/jmr.1095.

PMID:
21038355
21.

Combinatorial semisynthesis of biomarker-IgM complexes.

Veggiani G, Zuin J, Beneduce L, Gallotta A, Pengo P, Fassina G.

J Biomol Screen. 2010 Dec;15(10):1274-80. doi: 10.1177/1087057110378623. Epub 2010 Oct 11.

PMID:
20938047
22.

[Immunity and cancer: the role of PSA IgM Immune complexes for prostate cancer].

Zani D, Costa S, Beneduce L, Fassina G, Simeone C, Cosciani Cunico S.

Urologia. 2010 Jan-Mar;77(1):1-3. Italian.

PMID:
20890851
23.

SERPINB3 induces epithelial-mesenchymal transition.

Quarta S, Vidalino L, Turato C, Ruvoletto M, Calabrese F, Valente M, Cannito S, Fassina G, Parola M, Gatta A, Pontisso P.

J Pathol. 2010 Jul;221(3):343-56. doi: 10.1002/path.2708.

PMID:
20527027
24.

SERPINB3 modulates TGF-beta expression in chronic liver disease.

Turato C, Calabrese F, Biasiolo A, Quarta S, Ruvoletto M, Tono N, Paccagnella D, Fassina G, Merkel C, Harrison TJ, Gatta A, Pontisso P.

Lab Invest. 2010 Jul;90(7):1016-23. doi: 10.1038/labinvest.2010.55. Epub 2010 Mar 8.

25.

Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.

Zuin J, Veggiani G, Pengo P, Gallotta A, Biasiolo A, Tono N, Gatta A, Pontisso P, Toth R, Cerin D, Frecer V, Meo S, Gion M, Fassina G, Beneduce L.

Clin Chem Lab Med. 2010 Feb;48(2):217-23. doi: 10.1515/CCLM.2010.044.

PMID:
20001440
26.

Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice.

Villano G, Quarta S, Ruvoletto MG, Turato C, Vidalino L, Biasiolo A, Tono N, Lunardi F, Calabrese F, Dall'olmo L, Dedja A, Fassina G, Gatta A, Pontisso P.

Int J Mol Med. 2010 Jan;25(1):137-43.

PMID:
19956912
27.

Structural characterization of a Protein A mimetic peptide dendrimer bound to human IgG.

Moiani D, Salvalaglio M, Cavallotti C, Bujacz A, Redzynia I, Bujacz G, Dinon F, Pengo P, Fassina G.

J Phys Chem B. 2009 Dec 17;113(50):16268-75. doi: 10.1021/jp909405b.

PMID:
19924842
28.

[Psychoactive drugs and fitness to drive in the occupational field].

Paraluppi P, Fassina G, Ferrari G, Tronconi L.

G Ital Med Lav Ergon. 2009 Jan-Mar;31(1):33-6. Italian.

PMID:
19558037
29.

Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation.

Monteghirfo S, Tosetti F, Ambrosini C, Stigliani S, Pozzi S, Frassoni F, Fassina G, Soverini S, Albini A, Ferrari N.

Mol Cancer Ther. 2008 Sep;7(9):2692-702. doi: 10.1158/1535-7163.MCT-08-0132.

30.

Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease.

Turato C, Ruvoletto MG, Biasiolo A, Quarta S, Tono N, Bernardinello E, Beneduce L, Fassina G, Cavalletto L, Chemello L, Merkel C, Gatta A, Pontisso P.

Dig Liver Dis. 2009 Mar;41(3):212-6. doi: 10.1016/j.dld.2008.06.001. Epub 2008 Jul 25.

PMID:
18657489
31.

Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.

Beneduce L, Pesce G, Gallotta A, Zampieri F, Biasiolo A, Tono N, Boscato N, Gatta A, Pontisso P, Fassina G.

Eur J Clin Invest. 2008 Aug;38(8):571-7. doi: 10.1111/j.1365-2362.2008.01985.x.

PMID:
18625005
32.

Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis.

Biasiolo A, Chemello L, Quarta S, Cavalletto L, Bortolotti F, Caberlotto C, Beneduce L, Bernardinello E, Tono N, Fassina G, Gatta A, Pontisso P.

J Viral Hepat. 2008 Apr;15(4):246-9. doi: 10.1111/j.1365-2893.2007.00935.x. Epub 2008 Jan 30.

PMID:
18248333
33.

Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.

Beneduce L, Prayer-Galetti T, Giustinian AM, Gallotta A, Betto G, Pagano F, Fassina G.

Cancer Detect Prev. 2007;31(5):402-7. Epub 2007 Nov 26.

PMID:
18035503
34.

Inhibition of a vascular ocular tumor growth by IL-12 gene transfer.

Albini A, Fassina G, Nicolò M, Dell'Eva R, Vené R, Cammarota R, Barberis M, Noonan DM.

Clin Exp Metastasis. 2007;24(7):485-93. Epub 2007 Jul 25.

PMID:
17653825
35.

Expression pattern of squamous cell carcinoma antigen in oesophageal dysplasia and squamous cell carcinoma.

Parenti A, Porzionato A, Pizzi S, Guzzardo V, Fassina G, Macchi V, Ninfo V, De Caro R.

Histol Histopathol. 2007 Sep;22(9):989-95. doi: 10.14670/HH-22.989.

PMID:
17523076
36.

Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.

Pontisso P, Quarta S, Caberlotto C, Beneduce L, Marino M, Bernardinello E, Tono N, Fassina G, Cavalletto L, Gatta A, Chemello L.

Int J Cancer. 2006 Aug 15;119(4):735-40.

37.

Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets.

Albini A, Dell'Eva R, Vené R, Ferrari N, Buhler DR, Noonan DM, Fassina G.

FASEB J. 2006 Mar;20(3):527-9. Epub 2005 Dec 30.

PMID:
16403733
38.

Detection of circulating CEA-IgM complexes in early stage colorectal cancer.

Castaldi F, Marino M, Beneduce L, Belluco C, De Marchi F, Mammano E, Nitti D, Lise M, Fassina G.

Int J Biol Markers. 2005 Oct-Dec;20(4):204-8.

PMID:
16398401
39.

Further study of restored and un-restored teeth subjected to high temperatures.

Merlati G, Savlo C, Danesino P, Fassina G, Menghini P.

J Forensic Odontostomatol. 2004 Dec;22(2):34-9.

PMID:
16223018
40.

Radiographic evaluation of teeth subjected to high temperatures: experimental study to aid identification processes.

Savio C, Merlati G, Danesino P, Fassina G, Menghini P.

Forensic Sci Int. 2006 May 10;158(2-3):108-16. Epub 2005 Jun 29.

PMID:
15993019
41.

Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.

Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G.

Cancer. 2005 Jun 15;103(12):2558-65.

42.

Observations on dental structures when placed in contact with acids: experimental studies to aid identification processes.

Mazza A, Merlati G, Savio C, Fassina G, Menghini P, Danesino P.

J Forensic Sci. 2005 Mar;50(2):406-10.

PMID:
15813552
43.

Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc.

Nieddu E, Melchiori A, Pescarolo MP, Bagnasco L, Biasotti B, Licheri B, Malacarne D, Tortolina L, Castagnino N, Pasa S, Cimoli G, Avignolo C, Ponassi R, Balbi C, Patrone E, D'arrigo C, Barboro P, Vasile F, Orecchia P, Carnemolla B, Damonte G, Millo E, Palomba D, Fassina G, Mazzei M, Parodi S.

FASEB J. 2005 Apr;19(6):632-4. Epub 2005 Jan 25.

PMID:
15671156
44.

Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies.

van Rossum AP, Rarok AA, Huitema MG, Fassina G, Limburg PC, Kallenberg CG.

J Leukoc Biol. 2004 Dec;76(6):1162-70. Epub 2004 Aug 26.

PMID:
15331626
45.

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.

Fassina G, Venè R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A.

Clin Cancer Res. 2004 Jul 15;10(14):4865-73.

46.

Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.

Beneduce L, Castaldi F, Marino M, Tono N, Gatta A, Pontisso P, Fassina G.

Int J Biol Markers. 2004 Apr-Jun;19(2):155-9.

PMID:
15255549
47.

Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus.

Ruvoletto MG, Tono N, Carollo D, Vilei T, Trentin L, Muraca M, Marino M, Gatta A, Fassina G, Pontisso P.

J Gen Virol. 2004 Mar;85(Pt 3):621-4.

PMID:
14993646
48.

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.

Pontisso P, Calabrese F, Benvegnù L, Lise M, Belluco C, Ruvoletto MG, Marino M, Valente M, Nitti D, Gatta A, Fassina G.

Br J Cancer. 2004 Feb 23;90(4):833-7. Erratum in: Br J Cancer. 2004 Dec 13;91(12):2103.

49.

Fc gamma RIIIb allele-sensitive release of alpha-defensins: anti-neutrophil cytoplasmic antibody-induced release of chemotaxins.

Tanaka S, Edberg JC, Chatham W, Fassina G, Kimberly RP.

J Immunol. 2003 Dec 1;171(11):6090-6.

50.

Parapharyngeal abscess and sudden death.

Osculati A, Fassina G.

Leg Med (Tokyo). 1999 Sep;1(1):34-6.

PMID:
12935512

Supplemental Content

Loading ...
Support Center